Alzheimer's disease: a current review
Abstract
Alzheimer's disease is characterized by a progressive decline in cognitive function from a previously established level, and is the most common cause of all the dementias. While the exact etiology remains to be determined, there are several theories about possible genetic, immunological, biochemical and viral causes. Clinical diagnosis is by exclusion of other established causes of dementia and requires a careful history, physical examination and, often, psychological testing. Definitive diagnosis is made at post-mortem, although some cases show none of the histological hallmarks such as neurofibrillary tangles or senile plaques. There is no effective preventive or therapeutic treatment. Symptomatic management includes pharmacotherapy, socialization, support for the patient and his family and, ultimately, institutionalization. Patients are best managed by an interdisciplinary team using community resources.
Similar articles
-
Alzheimer's disease.Dis Mon. 1992 Jan;38(1):1-64. doi: 10.1016/0011-5029(92)90010-m. Dis Mon. 1992. PMID: 1727391 Review.
-
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):352-6. doi: 10.1136/jnnp.61.4.352. J Neurol Neurosurg Psychiatry. 1996. PMID: 8890772 Free PMC article.
-
[Diagnosis of Alzheimer's disease].Ann Biol Clin (Paris). 1998 Mar-Apr;56(2):133-42. Ann Biol Clin (Paris). 1998. PMID: 9754238 Review. French.
-
[Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].Ideggyogy Sz. 2006 May 20;59(5-6):164-77. Ideggyogy Sz. 2006. PMID: 16786711 Hungarian.
-
A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia.Psychiatry Res. 1993 Oct;49(1):41-62. doi: 10.1016/0165-1781(93)90029-g. Psychiatry Res. 1993. PMID: 8140181
Cited by
-
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.J Alzheimers Dis. 2018;62(3):965-992. doi: 10.3233/JAD-171145. J Alzheimers Dis. 2018. PMID: 29562546 Free PMC article. Review.
-
Back to the future: Alzheimer's disease heterogeneity revisited.Alzheimers Dement (Amst). 2015 Sep;1(3):368-370. doi: 10.1016/j.dadm.2015.05.006. Alzheimers Dement (Amst). 2015. PMID: 27077132 Free PMC article. No abstract available.
References
LinkOut - more resources
Full Text Sources